Hopital de l'Institut Curie

Paris 75005

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Cancer, Metastatic, HER2 Positive Breast Cancer

Studies at this site

• ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer — Recruiting now
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early